Suppr超能文献

罗哌卡因、布比卡因及其主要代谢物的液相色谱生物分析测定

Liquid chromatographic bioanalytical determination of ropivacaine, bupivacaine and major metabolites.

作者信息

Arvidsson T, Askemark Y, Halldin M M

机构信息

Astra Pain Control AB, Concept Division, Södertälje, Sweden.

出版信息

Biomed Chromatogr. 1999 Jun;13(4):286-92. doi: 10.1002/(SICI)1099-0801(199906)13:4<286::AID-BMC862>3.0.CO;2-M.

Abstract

Bioanalytical methods for the determination of ropivacaine, bupivacaine and their major metabolites in urine and blood plasma are presented. Ropivacaine is a new local anaesthetic drug mainly used for surgery and for postoperative pain relief. The samples are hydrolysed and cleaned using solid-phase extraction and analysed using ion-pair reversed-phase liquid chromatography with gradient elution. The analytes are detected using UV at 210 nm. The methods are highly selective and the limits of quantification were 1 microM in urine and 0.1 microM in plasma, respectively. The between-day variance was generally below 3% (RSD).

摘要

本文介绍了用于测定尿液和血浆中罗哌卡因、布比卡因及其主要代谢物的生物分析方法。罗哌卡因是一种新型局部麻醉药,主要用于手术及术后疼痛缓解。样品经水解后,采用固相萃取进行净化,并使用梯度洗脱的离子对反相液相色谱法进行分析。采用紫外检测器在210nm波长处检测分析物。这些方法具有高度选择性,定量限分别为尿液中1μM和血浆中0.1μM。日间差异一般低于3%(相对标准偏差)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验